Louisiana Sen. Bill Cassidy walked a narrow political line Wednesday as he questioned Health Secretary Robert F. Kennedy Jr. in two Senate hearings—balancing his medical background, his oversight responsibilities and his reelection fight in a closely watched Louisiana GOP primary. Cassidy chairs a Senate committee overseeing Kennedy’s department and also sits on another, giving him a formal role in shaping how the federal health agenda is scrutinized.
In the hearings, Cassidy asked Kennedy about how the administration would respond to vaccine-preventable outbreaks, including expected disease spread during large public events such as the World Cup and America 250. Cassidy also raised policy and oversight questions that extended beyond vaccines, including affordability, fraud and abortion drugs, and he pressed on the rise of diseases such as measles that can be prevented through childhood vaccination.
Cassidy said his approach reflected his professional experience. “I am a doctor who has seen people die from vaccine preventable diseases,” Cassidy said, adding that outbreaks numbering in the thousands can again bring deaths “particularly [of] children.” He also said vaccine trust has declined in the U.S. over the past year, and he asked Kennedy how HHS plans to address that risk.
Political consultant Mary-Patricia Wray said Cassidy’s tone combined caution and positioning. She described his stance as a “polite ‘I told you so,’” and said Cassidy reinforced the real-world consequences of declining vaccine confidence while signaling the administration’s posture was moving closer to where Cassidy has been as a physician. Another expert who studies congressional oversight, Claire Leavitt of Smith College, said Cassidy had taken an electoral risk in showing “any sort of resistance to RFK,” predicting it could carry a price.
Cassidy’s congressional role has long intersected with his medical views on childhood vaccines. As a physician, he advocated that babies receive hepatitis B vaccines shortly after birth, a step aimed at preventing disease in his patients. After Trump nominated Kennedy—an anti-vaccine activist—Cassidy supported the nomination, describing commitments he said he obtained, including that Kennedy would work within the current vaccine approval and safety monitoring system and support the childhood vaccine schedule.
But Cassidy’s support did not insulate him from political consequences. The president endorsed U.S. Rep. Julia Letlow, one of Cassidy’s two Republican primary opponents, in an unusual move that would attempt to unseat a sitting senator from the president’s own party. Cassidy also faces pressure from Kennedy’s allies in the “Make America Healthy Again” movement, and Wray said some of that group’s activity could intersect with the primary.
Cassidy said in earlier remarks that he was not sure what the movement’s conflict with him is. He told reporters: “I’m not really sure what MAHA’s beef is,” and added: “Let me point out that I am the reason that Robert F. Kennedy is now the secretary of HHS. He would not have gotten there otherwise.” Cassidy said he has “strongly supported” the movement’s agenda, including work related to ultraprocessed foods, while also acknowledging “disagreed on vaccines” with Kennedy.
Several experts said Cassidy’s vaccine stance may not hurt him as much with Republicans as some people assume. Dorit Reiss, a vaccine-law expert at UC Law San Francisco, said the political risk could be muted in part because Kennedy and the Trump administration have shifted away from vaccines in public discussions, emphasizing less contentious issues such as healthy eating. Reiss also said earlier “unfounded vaccine fears” entering government were part of what raised the stakes for Congress, and she expressed the view that Cassidy could have done more through additional hearings or legislation to limit Kennedy’s influence.
Others pointed to how Cassidy asked questions that could appeal to voters beyond the “Make America Healthy Again” base. Cassidy asked Kennedy why HHS had not reinstated an in-person dispensing requirement for chemical abortion drugs, a line of questioning Wray said helped Cassidy court non-MAHA Republicans who want the administration to act on their priorities. Wray also said Cassidy’s strategy suggested he was seeking to show he could “work[] with this administration” without “work[ing] for this administration.”
The hearings also highlighted what could be at stake if Cassidy fails to reach the November general election: his continued chair role in overseeing the Department of Health and Human Services as head of the Senate Health, Education, Labor and Pensions committee. Leavitt said seniority usually plays the biggest role in chairmanship, and she said another Republican in a more hyperpartisan Congress might be less willing to check Kennedy’s power. Reiss said Cassidy bears responsibility for allowing Kennedy into government and she called that moment Cassidy’s “original sin.”
Cassidy’s performance on Wednesday, experts said, could therefore shape not only his own electoral trajectory but also how Congress exercises oversight of HHS as public health debates continue amid distrust and misinformation.